Generation of cardiac spheres from primate pluripotent stem cells in a small molecule-based 3D system

Biomaterials

Volumn 65, Issue , 2015, Pages 103-114

  Jiang, Bin ^a,b   Xiang, Zhen ^a,b   Ai, Zongyong ^a,b   Wang, Hong ^a,b   Li, Yanjiao ^a,b   Ji, Weizhi ^a,b   Li, Tianqing ^a,b  

^a KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b National Engineering Research Center of Biomedicine and Animal Science   (China)

Author keywords

3D suspension culture of plurioptent stem cells; Cardiac maturity; Cardiac spheres; Primate embryonic stem cells; Small molecule based 3D differentiation

Indexed keywords

CYTOLOGY; DIAGNOSIS; DISEASE CONTROL; GENE EXPRESSION; HEART; MOLECULES; SPHERES;

3-D CULTURE SYSTEM; CARDIAC MATURITY; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILES; PHARMACOLOGICAL RESPONSE; PLURIPOTENT STEM CELLS; SMALL MOLECULES; SUSPENSION CULTURES;

STEM CELLS;

CALCIUM;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CARDIAC SPHERE; CELL DIFFERENTIATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; HEART DEVELOPMENT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIMATE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; ANIMAL; CARDIAC MUSCLE CELL; CELL CULTURE TECHNIQUE; CELL LINE; CYTOLOGY; EMBRYONIC STEM CELL; HEART CONTRACTION; MACACA FASCICULARIS; MULTICELLULAR SPHEROID; PROCEDURES;

PRIMATES;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; HUMANS; MACACA FASCICULARIS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; SPHEROIDS, CELLULAR;

EID: 84937430663     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.06.024     Document Type: Article

References (39)

1. Laflamme M.A., Murry C.E. Heart regeneration. Nature 2011, 473:326-335.
2. Caspi O., Huber I., Kehat I., Habib M., Arbel G., Gepstein A., et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J.Am. Coll. Cardiol. 2007, 50:1884-1893.
3. Shiba Y., Fernandes S., Zhu W.-Z., Filice D., Muskheli V., Kim J., et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 2012, 489:322-325.
4. Blin G., Nury D., Stefanovic S., Neri T., Guillevic O., Brinon B., et al. Apurified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J.Clin. Invest. 2010, 120:1125-1139.
5. Chong J.J.H., Yang X., Don C.W., Minami E., Liu Y.-W., Weyers J.J., et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 2014, 510:273-277.
6. Lian X., Hsiao C., Wilson G., Zhu K., Hazeltine L.B., Azarin S.M., et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. 2012, 109:E1848-E1857.
7. Mignone J.L., Kreutziger K.L., Paige S.L., Murry C.E. Cardiogenesis from human embryonic stem cells. Circ. J. 2010, 74:2517-2526.
8. Zhu W.-Z., Biber B., Laflamme M. Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells. Human Pluripotent Stem Cells 2011, 419-431. Humana Press. P.H. Schwartz, R.L. Wesselschmidt (Eds.).
9. Vidarsson H., Hyllner J., Sartipy P. Differentiation of human embryonic stem cells to cardiomyocytes for invitro and invivo applications. Stem Cell Rev. Rep. 2010, 6:108-120.
10. Burridge P.W., Anderson D., Priddle H., Barbadillo Muñoz M.D., Chamberlain S., Allegrucci C., et al. Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel v-96 plate aggregation system highlights interline variability. Stem Cells 2007, 25:929-938.
11. Peerani R., Rao B.M., Bauwens C., Yin T., Wood G.A., Nagy A., et al. Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J. 2007, 26:4744-4755.
12. Niebruegge S., Bauwens C.L., Peerani R., Thavandiran N., Masse S., Sevaptisidis E., et al. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol. Bioeng. 2009, 102:493-507.
13. Burridge P.W., Thompson S., Millrod M.A., Weinberg S., Yuan X., Peters A., et al. Auniversal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS ONE 2011, 6:e18293.
14. Mummery C.L., Zhang J., Ng E.S., Elliott D.A., Elefanty A.G., Kamp T.J. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circulation Res. 2012, 111:344-358.
15. Nguyen Doan C., Hookway Tracy A., Wu Q., Jha R., Preininger Marcela K., Chen X., et al. Microscale generation of cardiospheres promotes robust enrichment of cardiomyocytes derived from human pluripotent stem cells. Stem Cell. Rep. 2014, 3:260-268.
16. Serra M., Brito C., Correia C., Alves P.M. Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol. 2012, 30:350-359.
17. Burridge Paul W., Keller G., Gold Joseph D., Wu Joseph C. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell. Stem Cell. 2012, 10:16-28.
18. Liu H., Zhu F., Yong J., Zhang P., Hou P., Li H., et al. Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell. Stem Cell. 2008, 3:587-590.
19. Tomomi G. Otsuji, J. Bin, A. Yoshimura, M. Tomura, D. Tateyama, I. Minami, etal. A 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell production, Stem Cell. Rep. 2: p. 734-745.
20. Ludwig T.E., Levenstein M.E., Jones J.M., Berggren W.T., Mitchen E.R., Frane J.L., et al. Derivation of human embryonic stem cells in defined conditions. Nat. Biotech. 2006, 24:185-187.
21. Takahashi T., Lord B., Schulze P.C., Fryer R.M., Sarang S.S., Gullans S.R., Lee R.T. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 2003, 107:1912-1916.
22. Cao N., Liu Z., Chen Z., Wang J., Chen T., Zhao X., et al. Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell. Res. 2012, 22:219-236.
23. Brodsky V.Y., Arefyeva A.M., Gvasava I.G., Sarkisov D.S., Panova N.W. Polyploidy in cardiac myocytes of normal and hypertrophic human hearts; range of values. Virchows Arch. 1994, 424:429-435.
24. Liu Z., Yue S., Chen X., Kubin T., Braun T. Regulation of cardiomyocyte polyploidy and multinucleation by cyclinG1. Circulation Res. 2010, 106:1498-1506.
25. Lundy S.D., Zhu W.Z., Regnier M., Laflamme M.A. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev. 2013, 22:1991-2002.
26. Synnergren J., Améen C., Jansson A., Sartipy P. Global Transcriptional Profiling Reveals Similarities and Differences Between Human Stem Cell-derived Cardiomyocyte Clusters and Heart Tissue 2012, vol. 44:245-258.
27. Sato H., Takahashi M., Ise H., Yamada A., Hirose S.-i., Tagawa Y.-i., et al. Collagen synthesis is required for ascorbic acid-enhanced differentiation of mouse embryonic stem cells into cardiomyocytes. Biochem. Biophysical Res. Commun. 2006, 342:107-112.
28. Jakobsson L., Domogatskaya A., Tryggvason K., Edgar D., Claesson-Welsh L. Laminin deposition is dispensable for vasculogenesis but regulates blood vessel diameter independent of flow. FASEB J. 2008, 22:1530-1539.
29. Ross R.S., Borg T.K. Integrins and the myocardium. Circulation Res. 2001, 88:1112-1119.
30. Itzhaki I., Rapoport S., Huber I., Mizrahi I., Zwi-Dantsis L., Arbel G., et al. Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PLoS ONE 2011, 6:e18037.
31. Burridge P.W., Matsa E., Shukla P., Lin Z.C., Churko J.M., Ebert A.D., et al. Chemically defined generation of human cardiomyocytes. Nat. Methods 2014, 11:855-860.
32. Estigoy C., Pontén F., Odeberg J., Herbert B., Guilhaus M., Charleston M., et al. Intercalated discs: multiple proteins perform multiple functions in non-failing and failing human hearts. Biophys. Rev. 2009, 1:43-49.
33. Remme C.A., Bezzina C.R. Cardiac desmosomal (dys)function and myocyte viability. Cell. Cycle 2010, 9:1246-1252.
34. Rohr S. Role of gap junctions in the propagation of the cardiac action potential. Cardiovasc. Res. 2004, 62:309-322.
35. Mummery C.L., Zhang J., Ng E.S., Elliott D.A., Elefanty A.G., Kamp T.J. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ. Res. 2012, 111:344-358.
36. Kattman S.J., Witty A.D., Gagliardi M., Dubois N.C., Niapour M., Hotta A., et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell. Stem Cell. 2011, 8:228-240.
37. Elliott D.A., Braam S.R., Koutsis K., Ng E.S., Jenny R., Lagerqvist E.L., et al. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat. Methods 2011, 8:1037-1040.
38. Yang L., Soonpaa M.H., Adler E.D., Roepke T.K., Kattman S.J., Kennedy M., et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
39. Willems E., Cabral-Teixeira J., Schade D., Cai W., Reeves P., Bushway P.J., et al. Small molecule-mediated TGF-beta type II receptor degradation promotes cardiomyogenesis in embryonic stem cells. Cell. Stem Cell. 2012, 11:242-252.